Dana Feuchtbaum

Dana Feuchtbaum currently serves as the Chief Product Officer at Iterative Health, a position held since June 2023. Prior experience includes roles as SVP of Product at Nym and Senior Director of Product Management at Flatiron Health, among others. Dana has engaged in strategic consulting at The Avascent Group, providing management support to clients across civil and defense markets. Educational achievements include an MBA from Harvard Business School and a Bachelor of Arts in International Relations from Brown University, complemented by study at SOAS University of London.